Primrose Bio raises growth round led by Signet Healthcare Partners
Primrose Bio Issuer · Signet Healthcare Partners Lead investor · 1315 Capital Investor · Ligand Pharmaceuticals Investor · LDV Partners Investor · Agent Capital Investor
Intelligence
The deal
- Type
- Funding
- Amount
- Not recorded
- Status
- Closed
- Round
- growth capital
- Valuation
- Not recorded
- Region
- United States
- Date
- 22 September 2026
As of this development: a later development may record new terms.
Lifecycle
- Announced
- Closed
The parties
Primrose Bio Issuer
Signet Healthcare Partners Lead investor
1315 Capital Investor
Ligand Pharmaceuticals Investor
Activity